Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis.

Ana Cristina Medeiros-RibeiroKarina Rossi BonfiglioliDiogo Souza DomicianoAndrea Yukie ShimabucoHenrique Carriço da SilvaCarla G S SaadEmily Figueiredo Neves YukiSandra Gofinet PasotoCarlo Scognamiglio Renner AraujoTatiane Lie NakaiClóvis Artur SilvaTatiana PedrosaLéonard de Vinci Kanda KupaMatheus Santos Rodrigues SilvaGuilherme Guimarães Moreira BalbiEsper Georges KallasNádia Emi Aikawa Eloisa S Bonfa

Published in: Annals of the rheumatic diseases (2022)

NCT04754698.

Keyphrases

sars cov
rheumatoid arthritis
respiratory syndrome coronavirus
combination therapy
disease activity
open label
interstitial lung disease
ankylosing spondylitis
idiopathic pulmonary fibrosis